High plasma VEGF concentrations are associated with less carbohydrate intake and lower body mass in type II diabetes, and over expression of VEGF by the adipose tissue protects against diet-induced obesity and insulin resistance. The gene discussed is VEGFA; the disease is obesity due to melanocortin 4 receptor deficiency.